Advantage Cat 40 40 mg/0.4 ml Oplossing voor cutaan gebruik
Advantage Cat 40 40 mg/0.4 ml Oplossing voor cutaan gebruik
Authorised
- Imidacloprid
Product identification
Medicine name:
Advantage Cat 40 40 mg/0.4 ml Oplossing voor cutaan gebruik
Advantage Cat 40 40 mg/0.4 ml Solution pour application cutanée
Advantage Cat 40 40 mg/0.4 ml Lösung zur Anwendung auf der Haut
Active substance:
- Imidacloprid
Target species:
-
Cat
Route of administration:
-
Cutaneous use
Product details
Active substance and strength:
-
Imidacloprid40.00/milligram(s)0.40millilitre(s)
Pharmaceutical form:
-
Cutaneous solution
Withdrawal period by route of administration:
-
Cutaneous use
- Cat
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QP53AX17
Legal status of supply:
-
Veterinary medicinal product not subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Belgium
Available in:
-
Belgium
Package description:
- Advantage Cat 40 6 Pipettes with 0.4 ml of Cutaneous solution
- Advantage Cat 40 4 Pipettes with 0.4 ml of Cutaneous solution
- Advantage Cat 40 3 Pipettes with 0.4 ml of Cutaneous solution
- Advantage Cat 40 2 Pipettes with 0.4 ml of Cutaneous solution
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Informed Consent application (Article 21 of Regulation (EU) 2019/6)
Marketing authorisation holder:
- Elanco Animal Health GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
- KVP Pharma+Veterinär Produkte GmbH
Responsible authority:
- Federal Agency For Medicines And Health Products
Authorisation number:
- BE-V459724
Date of authorisation status change:
Informed consent reference:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it in another language below.
Package Leaflet
This document does not exist in this language (English). You can find it in another language below.
How useful was this page?:
